NCT00337818View on ClinicalTrials.gov

Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women

PHASE3CompletedINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

January 31, 2009

Conditions
Papillomavirus Type 16/18 InfectionCervical Intraepithelial Neoplasia
Interventions
BIOLOGICAL

Cervarix™

Three doses of vaccine according to a 0, 1, 6 month schedule (during the primary study)

Trial Locations (1)

1162

GSK Investigational Site, Tallinn

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY